TGFB1 and neoplasm: Klotho is an established tumor suppressor, epigenetically silenced in breast and other cancers [31, 32, 53–55] since it inhibits signaling pathways, such as IGF-1, PI3K, WNT, and TGFβ [30, 56–58].